CardioInsight Technologies, a US-based healthcare company previously backed by Japan-based distributor of cardiovascular devices DVX, has raised $7.5m.
It is unclear which companies backed the series C financing. The company is focussed on getting regulatory clearance for its electrocardiographic mapping technology from US regulator the Food and Drug Administration, it said. The company has already secured CE Mark certification allowing it to sell its product in the European Union.
In January 2011 CardioInsight raised more than $10m from DVX and venture capital firms Draper Triangle Ventures, which led the financing, and Case Technology Ventures, which makes pre-seed stage investments out of Case Western Reserve University. The company raised $750,000 in 2006, when it span off from Case Western Reserve University in a round also backed by Jumpstart, an accelerator.
CardioInsight has put in place commercial installations at St. Mary’s Hospital in London, England, the Kerckhoff Clinic in Bad Nauheim, Germany and the Hopital Cardiologique du Haut-Leveque in Bordeaux, France.